TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Global Pharma Consulting (GPC) AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
73
|
56
|
85 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
-1
|
-32
|
-12 |
| EBITDA |
0
|
-32
|
-12 |
| Total assets |
51
|
43
|
72 |
| Current assets |
51
|
43
|
72 |
| Current liabilities |
47
|
38
|
59 |
| Equity capital |
4
|
5
|
13 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
7.8%
|
11.6%
|
18.1% |
| Turnover per employee |
73
|
56
|
85 |
| Profit as a percentage of turnover |
-1.4%
|
-57.1%
|
-14.1% |
| Return on assets (ROA) |
0%
|
-74.4%
|
-16.7% |
| Current ratio |
108.5%
|
113.2%
|
122.0% |
| Return on equity (ROE) |
-25.0%
|
-640.0%
|
-92.3% |
| Change turnover |
17
|
-22
|
-109 |
| Change turnover % |
30%
|
-29%
|
-56% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.